Vertex Is The First To Get NaV1.8 To Proof Of Concept For Pain
Effort Is Built On Decades Of Sodium Channel Research
Chief scientific officer David Altshuler talked to Scrip about the late-stage development plan for a drug that could represent a blockbuster-sized commercial opportunity, after two Phase II studies testing VX-548 met their primary endpoints.
